Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma

Xia Zheng(Ningbo University), Shukui Qin(Memorial Sloan Kettering Cancer Center)

Frontiers in Oncology

October 26, 2021

10.3389/fonc.2021.740557

Cited by 37

Related Papers

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer

|NEJM Evidence|2022|1.1k

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer

|Nature|2021|687

Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial

|The Lancet|2023|461

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

|The Lancet. Gastroenterology & hepatology|2024|245

Ginsenoside 20(S)-Rg3 Prevents PKM2-Targeting miR-324-5p from H19 Sponging to Antagonize the Warburg Effect in Ovarian Cancer Cells

|Cellular Physiology and Biochemistry|2018|87